The main reason for the downturn in Moderna’s stock is a significant drop in the demand for its COVID-19 vaccine.

Is ENPH stock a worthwhile purchase following such a considerable drop? This steep decrease for Enphase Energy stands out ...

Q1 2026 Earnings Call Transcript June 6, 2025 Operator: Good afternoon, ladies and gentlemen. Thank you for joining ...

Investors are cheering signs of a potential truce in the acrimonious feud between President Trump and Elon Musk, and a ...

For the full year, management raised its guidance, with revenue now at $3.151 billion-$3.163 billion from $3.129 ...

Docusign shares were down 17% at $757.58 in early trading following its earnings, released after the market closed on ...

DocuSign's Q1'26 earnings beat estimates, showcasing 30% FCF margins and raised outlook. Find out why I am upgrading DOCU ...

Shares of DocuSign tanked 18% in trading on Friday, a day after the e-signature provider reported stronger-than-expected ...

DocuSign remains a 'Buy' with a $95 target. See more on DOCU stock's international growth, AI integration, and strong ...

Docusign offers Agreement Cloud, a broad cloud-based software suite that enables users to automate the agreement process and ...

JP Morgan analyst maintains Neutral rating on DocuSign with $81 price forecast ahead of earnings report. Upside potential and ...

This edition of Market Factors includes a thematic investing approach uncovering stocks that outperform. New stresses in the ...